These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 19172539)

  • 1. Coronary heart disease and HRT in France: MISSION study prospective phase results.
    Mares P; Chevallier T; Micheletti MC; Daures JP; Postruznik D; De Reilhac P
    Gynecol Endocrinol; 2008 Dec; 24(12):696-700. PubMed ID: 19172539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer incidence and hormone replacement therapy: results from the MISSION study, prospective phase.
    Espié M; Daures JP; Chevallier T; Mares P; Micheletti MC; De Reilhac P
    Gynecol Endocrinol; 2007 Jul; 23(7):391-7. PubMed ID: 17701770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer in postmenopausal women with and without hormone replacement therapy: preliminary results of the MISSION study.
    Espié M; Mares P; de Reilhac P; Chevallier T; Daurès JP
    Gynecol Endocrinol; 2006 Aug; 22(8):423-31. PubMed ID: 17012103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
    Windler E; Zyriax BC; Eidenmüller B; Boeing H
    Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The changing view of hormone replacement therapy.
    Vogel RA
    Rev Cardiovasc Med; 2003; 4(2):68-71. PubMed ID: 12776015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Living arrangement and coronary heart disease: the JPHC study.
    Ikeda A; Iso H; Kawachi I; Yamagishi K; Inoue M; Tsugane S;
    Heart; 2009 Apr; 95(7):577-83. PubMed ID: 19066191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of calcium supplements and the risk of coronary heart disease in 52-62-year-old women: The Kuopio Osteoporosis Risk Factor and Prevention Study.
    Pentti K; Tuppurainen MT; Honkanen R; Sandini L; Kröger H; Alhava E; Saarikoski S
    Maturitas; 2009 May; 63(1):73-8. PubMed ID: 19394167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of physicians' advice and recommendations on the compliance with hormone replacement therapy in the treatment of postmenopausal symptoms in Japanese women--a prospective study.
    Ushiroyama T; Ikeda A; Sakuma K; Ueki M
    J Med; 2004; 35(1-6):163-9. PubMed ID: 18084874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
    Banks E; Canfell K
    Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone replacement therapy and cardiovascular disease revisited.
    Stevenson JC
    Menopause Int; 2009 Jun; 15(2):55-7. PubMed ID: 19465669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A high menaquinone intake reduces the incidence of coronary heart disease.
    Gast GC; de Roos NM; Sluijs I; Bots ML; Beulens JW; Geleijnse JM; Witteman JC; Grobbee DE; Peeters PH; van der Schouw YT
    Nutr Metab Cardiovasc Dis; 2009 Sep; 19(7):504-10. PubMed ID: 19179058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between coronary heart disease and chronic renal insufficiency.
    Sologhashvili M
    Georgian Med News; 2006 Mar; (132):47-50. PubMed ID: 16636379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-reported data on reproductive variables were reliable among postmenopausal women.
    Lucas R; Azevedo A; Barros H
    J Clin Epidemiol; 2008 Sep; 61(9):945-50. PubMed ID: 18468857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of obesity to heart failure hospitalization and cardiovascular events in persons with stable coronary heart disease (from the Heart and Soul Study).
    Spies C; Farzaneh-Far R; Na B; Kanaya A; Schiller NB; Whooley MA
    Am J Cardiol; 2009 Oct; 104(7):883-9. PubMed ID: 19766751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Stramba-Badiale M
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):303-9. PubMed ID: 19430340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can menopausal hormone therapy prevent coronary heart disease?
    Brinton EA; Hodis HN; Merriam GR; Harman SM; Naftolin F
    Trends Endocrinol Metab; 2008 Aug; 19(6):206-12. PubMed ID: 18450469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone replacement therapy in women with systemic lupus erythematosus and risk of cardiovascular disease.
    Hochman J; Urowitz MB; Ibañez D; Gladman DD
    Lupus; 2009 Apr; 18(4):313-7. PubMed ID: 19276299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasomotor symptoms and mortality: the Rancho Bernardo Study.
    Svartberg J; von Mühlen D; Kritz-Silverstein D; Barrett-Connor E
    Menopause; 2009; 16(5):888-91. PubMed ID: 19421076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alcohol consumption, social support, and risk of stroke and coronary heart disease among Japanese men: the JPHC Study.
    Ikehara S; Iso H; Yamagishi K; Yamamoto S; Inoue M; Tsugane S;
    Alcohol Clin Exp Res; 2009 Jun; 33(6):1025-32. PubMed ID: 19302085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HRT and cardiovascular disease.
    Stevenson JC
    Best Pract Res Clin Obstet Gynaecol; 2009 Feb; 23(1):109-20. PubMed ID: 19095500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.